Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004324 · ClinicalTrials.gov registry record
Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- 90
- Enrollment target
NCT00004324: Completed study, sponsored by National Center for Research Resources (NCRR).
NCT00004324 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004324 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Characterize the natural history, associated features, and severity of symptoms of obsessive compulsive disorder and Tourette syndrome in children and adolescents. II. Identify factors that influence the clinical course and prognosis of these patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 1989-12 |
What the finished NCT00004324 record still lists
NCT00004324 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00004324 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004324 about?
NCT00004324 is a clinical study titled "Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents". OBJECTIVES: I. Characterize the natural history, associated features, and severity of symptoms of obsessive compulsive disorder and Tourette syndrome in children and adolescents. II. Identify factors that influence the clinical course and prognosis of these patients.
What is the current status of trial NCT00004324?
This trial is currently completed. The enrollment target is 90 participants. The study started on 1989-12.
Who is sponsoring clinical trial NCT00004324?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia